durapatite has been researched along with Leukemia P388 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, H; Deng, B; Huang, J; Li, G; Li, Y; Zhang, J; Zhang, R | 1 |
| Aoki, H; Deng, BF; Huang, JM; Li, G; Li, Y; Zhang, R | 1 |
| Kanter, PM; Schwartz, HS | 1 |
3 other study(ies) available for durapatite and Leukemia P388
| Article | Year |
|---|---|
In vitro study on influence of a discrete nano-hydroxyapatite on leukemia P388 cell behavior.
Topics: Animals; Biocompatible Materials; Cell Cycle; Cell Line, Tumor; Cell Survival; Collagen; Dose-Response Relationship, Drug; Durapatite; Leukemia P388; Mice; Particle Size | 2007 |
[In vivo study on influence of a discrete nano-hydroxyapatite on leukemia P388 tissue in BALB/C mice].
Topics: Animals; Biocompatible Materials; Calcium Hydroxide; Cell Line, Tumor; Durapatite; Female; Leukemia P388; Male; Mice; Mice, Inbred BALB C; Nanoparticles; X-Ray Diffraction; X-Rays | 2007 |
A fluorescence enhancement assay for cellular DNA damage.
Topics: Animals; Antineoplastic Agents; Cells, Cultured; Chromatography; DNA; DNA, Neoplasm; Durapatite; Fluorometry; Hydroxyapatites; Leukemia L1210; Leukemia P388; X-Rays | 1982 |